Related Experiment Videos
Targeted substrate degradation by an engineered double RING ubiquitin ligase
Daisuke Oyake1, Hiroyuki Nishikawa, Izumi Koizuka
1Department of Surgery, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawaski 216-8511, Japan.
Biochemical and Biophysical Research Communications
|August 2, 2002
Summary
Researchers engineered a novel double RING finger ubiquitin ligase to target specific proteins. This tool effectively degrades the target protein p57, offering potential for gene product regulation.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Ubiquitin ligases control protein degradation via the ubiquitin-proteasome pathway.
- Substrate recognition is key to ubiquitin ligase specificity.
Purpose of the Study:
- To design and validate a double RING finger ubiquitin ligase for targeted protein degradation.
- To assess the ligase's ability to specifically target and reduce the expression of cyclin-dependent kinase inhibitor p57.
Main Methods:
- Engineered a fusion protein combining BRCA1 and BARD1 RING finger domains with PCNA as a substrate recognition site.
- Co-transfected the engineered ligase into U2OS cells.
- Assessed p57 protein levels and cellular proliferation (colony formation).
Main Results:
- The engineered double RING finger ubiquitin ligase formed a complex and showed significant ligase activity.
- Co-transfection reduced p57 expression to background levels in a proteasome-dependent manner.
- Restored U2OS cell colony formation inhibited by p57 overexpression.
Conclusions:
- The engineered double RING ubiquitin ligase successfully targeted the intended substrate (p57).
- This engineered ligase demonstrates potential as a tool for protein level gene product removal by redesigning the substrate recognition site.